Sotera Health (NASDAQ:SHC) Receives Average Rating of “Moderate Buy” from Analysts

Shares of Sotera Health (NASDAQ:SHC) have earned an average rating of “Moderate Buy” from the six brokerages that are covering the company, Marketbeat Ratings reports. Two investment analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. The average 12-month price objective among brokers that have issued ratings on the stock in the last year is $15.70.

A number of analysts recently issued reports on the stock. Barclays raised their price objective on shares of Sotera Health from $14.00 to $17.00 and gave the stock an “overweight” rating in a report on Tuesday, August 6th. Royal Bank of Canada reaffirmed an “outperform” rating and issued a $17.00 price target on shares of Sotera Health in a report on Tuesday, August 6th.

Sotera Health Price Performance

Shares of NASDAQ SHC opened at $16.76 on Wednesday. The company has a market capitalization of $4.74 billion, a PE ratio of 88.21 and a beta of 2.07. The company has a quick ratio of 2.59, a current ratio of 2.93 and a debt-to-equity ratio of 5.46. The stock’s 50 day moving average price is $15.24 and its 200-day moving average price is $12.94. Sotera Health has a twelve month low of $10.71 and a twelve month high of $17.44.

Sotera Health (NASDAQ:SHC) last announced its quarterly earnings data on Monday, August 5th. The company reported $0.19 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.15 by $0.04. The firm had revenue of $277.00 million during the quarter, compared to the consensus estimate of $266.45 million. Sotera Health had a return on equity of 47.26% and a net margin of 3.65%. The business’s revenue for the quarter was up 8.6% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.19 EPS. On average, equities analysts anticipate that Sotera Health will post 0.64 EPS for the current year.

Insider Activity

In related news, Director Gtcr Investment Xi Llc sold 10,000,000 shares of the firm’s stock in a transaction that occurred on Friday, September 6th. The shares were sold at an average price of $15.03, for a total value of $150,300,000.00. Following the completion of the transaction, the director now directly owns 49,215,301 shares of the company’s stock, valued at approximately $739,705,974.03. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Insiders own 55.12% of the company’s stock.

Institutional Inflows and Outflows

A number of hedge funds have recently added to or reduced their stakes in SHC. Charles Schwab Investment Management Inc. grew its position in shares of Sotera Health by 1.9% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 898,320 shares of the company’s stock valued at $15,137,000 after purchasing an additional 16,401 shares in the last quarter. Dimensional Fund Advisors LP increased its stake in Sotera Health by 22.3% in the 4th quarter. Dimensional Fund Advisors LP now owns 1,992,717 shares of the company’s stock worth $33,581,000 after acquiring an additional 363,628 shares during the last quarter. Norges Bank bought a new stake in shares of Sotera Health during the 4th quarter valued at about $16,432,000. Quest Partners LLC purchased a new position in shares of Sotera Health during the fourth quarter worth about $139,000. Finally, TD Asset Management Inc grew its holdings in shares of Sotera Health by 10.7% during the fourth quarter. TD Asset Management Inc now owns 90,538 shares of the company’s stock worth $1,526,000 after purchasing an additional 8,738 shares in the last quarter. Hedge funds and other institutional investors own 91.03% of the company’s stock.

Sotera Health Company Profile

Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems.